HC grants status quo to Medlay

Excelsior Correspondent
Srinagar, May 3: The State High Court today granted status quo to the proceedings against M/S Medlay Pharmaceuticals, a week after the special TADA court issued non-bailable warrant against its owner and 14 other persons in spurious drug scam.
Justice J R Kotwal while hearing the petition of the M/S Medlay Pharmaceuticals issued notice to the Drug Inspector Srinagar who produced challan against manufacturers and suppliers of spurious drug Maxamizine-625 to Government hospitals in the State.
M/S Medlay Pharmaceuticals is seeking quashing of complaint filed by the Drug Inspector Srinagar against him and non-bail able the order against of the TADA court.
Earlier a special TADA court in Srinagar issued non-bailable arrest warrant against 15 suppliers and manufacturers of a spurious drug Maxamizine-625 to Government hospitals in the State.
It may be mentioned here that Excelsior broke the spurious drug scam early this month leading to registering of cases against suppliers and manufacturers of Maxamizine-625 drug that was supplied to hospitals across Kashmir valley. The antibiotic tested negative for amoxicillin while the company had claimed that it contains 500 miligramme of amoxicillin.
The drug, Maximizane 625 milligram, along with several other drugs were chosen in random sampling for laboratory testing by the Drug Controller Kashmir during winter. The drugs were sent to the laboratory for testing and the anti-biotic tested negative as the laboratory report revealed that it contains “NIL” Amoxicillin. The drug contained Zero milligrams of Amoxicillin tri-hydrate while the company claims that it contains 500 milligrams of Amoxicillin tri-hydrate + 125 milligrams clavulanic acid.